Viewing Study NCT01501669


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-31 @ 12:39 AM
Study NCT ID: NCT01501669
Status: UNKNOWN
Last Update Posted: 2012-07-18
First Post: 2011-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Sponsor: National Cancer Center, Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module